Login to Your Account



Dyax Regains All DX-88 Rights, $17M; Ends JV With Genzyme

By Jennifer Boggs


Thursday, February 22, 2007
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription